102 related articles for article (PubMed ID: 9622931)
21. An SOS-regulated operon involved in damage-inducible mutagenesis in Caulobacter crescentus.
Galhardo RS; Rocha RP; Marques MV; Menck CF
Nucleic Acids Res; 2005; 33(8):2603-14. PubMed ID: 15886391
[TBL] [Abstract][Full Text] [Related]
22. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
23. Bacterial non-host resistance: interactions of Arabidopsis with non-adapted Pseudomonas syringae strains.
Mishina TE; Zeier J
Physiol Plant; 2007 Nov; 131(3):448-61. PubMed ID: 18251883
[TBL] [Abstract][Full Text] [Related]
24. Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution.
Huang S
Prog Biophys Mol Biol; 2012 Sep; 110(1):69-86. PubMed ID: 22579660
[TBL] [Abstract][Full Text] [Related]
25. An evolutionary model of carcinogenesis.
Gatenby RA; Vincent TL
Cancer Res; 2003 Oct; 63(19):6212-20. PubMed ID: 14559806
[TBL] [Abstract][Full Text] [Related]
26. Apoptotic versus genotoxic potential of anti-tumor agents: a concept of duality in unity.
Bajic V; Milicevic Z; Potpervic-Spremo B; Nedeljkovic-Kurepa A
Med Hypotheses; 2003; 61(5-6):643-50. PubMed ID: 14592801
[TBL] [Abstract][Full Text] [Related]
27. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
[TBL] [Abstract][Full Text] [Related]
28. [Environmental mutagenesis and use of biomarkers in cancer risk prediction].
Cuenca P; Ramírez V
Rev Biol Trop; 2004 Sep; 52(3):585-90. PubMed ID: 17361552
[TBL] [Abstract][Full Text] [Related]
29. Aeons of distress: an evolutionary perspective on the bacterial SOS response.
Erill I; Campoy S; Barbé J
FEMS Microbiol Rev; 2007 Nov; 31(6):637-56. PubMed ID: 17883408
[TBL] [Abstract][Full Text] [Related]
30. Some aspects of the SOS response system--a critical survey.
Janion C
Acta Biochim Pol; 2001; 48(3):599-610. PubMed ID: 11833768
[TBL] [Abstract][Full Text] [Related]
31. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
Rak J; Yu JL
Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
[TBL] [Abstract][Full Text] [Related]
32. Combinatorial genetic evolution of multiresistance.
Walsh TR
Curr Opin Microbiol; 2006 Oct; 9(5):476-82. PubMed ID: 16942901
[TBL] [Abstract][Full Text] [Related]
33. Lipoxygenase metabolism: roles in tumor progression and survival.
Pidgeon GP; Lysaght J; Krishnamoorthy S; Reynolds JV; O'Byrne K; Nie D; Honn KV
Cancer Metastasis Rev; 2007 Dec; 26(3-4):503-24. PubMed ID: 17943411
[TBL] [Abstract][Full Text] [Related]
34. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
35. [Taxon-specific regulation of SOS-response in gamma-proteobacteria].
Sycheva LV; Permina EA; Gel'fand MS
Mol Biol (Mosk); 2007; 41(5):908-17. PubMed ID: 18240573
[TBL] [Abstract][Full Text] [Related]
36. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
[TBL] [Abstract][Full Text] [Related]
37. Cancer as a survival program of individual cells inherited from prokaryotes, conserved but repressed in cells from higher organisms and unveiled by environmental aggressions.
Israël L
Ann Med Interne (Paris); 1996; 147(6):387-8. PubMed ID: 9092339
[No Abstract] [Full Text] [Related]
38. Atherosclerosis and cancer: common molecular pathways of disease development and progression.
Ross JS; Stagliano NE; Donovan MJ; Breitbart RE; Ginsburg GS
Ann N Y Acad Sci; 2001 Dec; 947():271-92; discussion 292-3. PubMed ID: 11795276
[TBL] [Abstract][Full Text] [Related]
39. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
Haslberger A; Varga F; Karlic H
Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
[TBL] [Abstract][Full Text] [Related]
40. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
Nair S; Li W; Kong AN
Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
